<DOC>
	<DOCNO>NCT01154634</DOCNO>
	<brief_summary>The purpose study investigate pharmacodynamic effect AZD2516 healthy male subject .</brief_summary>
	<brief_title>Study Investigate Pharmacodynamic Effect Single Dose AZD2516 Healthy Male Subjects</brief_title>
	<detailed_description>A double-blind , randomize , placebo-controlled , two-centre , phase IIa pharmacodynamic cross-over study assess effect AZD2516 total number reflux episodes healthy male volunteer .</detailed_description>
	<criteria>Provision sign informed consent Healthy male subject Age 1845 year , inclusive Clinically significant illness within 2 week prior first dose study drug History clinically significant cardiovascular , respiratory , renal , hepatic , neurological , mental gastrointestinal disease Need concomitant medication study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Pharmacodynamic effect</keyword>
	<keyword>Reflux inhibition</keyword>
</DOC>